QCG
RGNX icon

Quadrant Capital Group’s Regenxbio RGNX Stock Holding History

Quadrant Capital Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-673
Closed -$5.64K – 2277
2026
Q1 		$5.64K Buy
673
+19
+3% +$200 ﹤0.01% 2329
2025
Q4 		$9.42K Buy
654
+528
+419% +$6.58K ﹤0.01% 2220
2025
Q3 		$1.22K Buy
+126
New +$1.11K ﹤0.01% 2544
2025
Q2 		– Sell
-734
Closed -$5.25K – 2321
2025
Q1 		$5.25K Sell
734
-1,903
-72% -$14.2K ﹤0.01% 2345
2024
Q4 		$20.4K Buy
2,637
+825
+46% +$7.75K ﹤0.01% 1887
2024
Q3 		$19K Buy
1,812
+1,219
+206% +$14.9K ﹤0.01% 1914
2024
Q2 		$6.94K Buy
593
+545
+1,135% +$8.48K ﹤0.01% 2216
2024
Q1 		$1.01K Sell
48
-342
-88% -$6.09K ﹤0.01% 2586
2023
Q4 		$7K Buy
390
+274
+236% +$4.83K ﹤0.01% 2190
2023
Q3 		$1.91K Sell
116
-134
-54% -$2.43K ﹤0.01% 2404
2023
Q2 		$5K Buy
250
+233
+1,371% +$4.49K ﹤0.01% 2205
2023
Q1 		$322 Buy
+17
New +$376 ﹤0.01% 2644
2021
Q4 		– Sell
-8
Closed – – 2664
2021
Q3 		$0 Buy
+8
New +$288 ﹤0.01% 2622
2020
Q3 		– Sell
-24
Closed -$1K – 2282
2020
Q2 		$1K Buy
+24
New +$895 ﹤0.01% 2116
2019
Q2 		– Sell
-15
Closed – – 2387
2019
Q1 		$0 Buy
+15
New +$743 ﹤0.01% 2317

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Quadrant Capital Group's RGNX Position: Q2 2026 in Review

Quadrant Capital Group sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 673 shares — an estimated $5.64K sold.

Quadrant Capital Group first reported a position in RGNX in Q1 2019 and held it in 15 quarters. The position peaked at $20.4K in Q4 2024. 164 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Quadrant Capital Group reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 673 Regenxbio shares in Q2 2026, an estimated $5.64K.
  • Quadrant Capital Group first reported a position in Regenxbio in Q1 2019 and held it in 15 quarters.
  • Quadrant Capital Group's Regenxbio position peaked at $20.4K in Q4 2024.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.